Jpmorgan Chase & CO Kala Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.3 - $1.31 $16,284 - $71,108	-54,281 Reduced 97.17%	1,583 $0
Q1 2022 May 11, 2022	SELL	$0.61 - $1.84 $3,089 - $9,317	-5,064 Reduced 8.31%	55,864 $77,000
Q4 2021 Feb 10, 2022	SELL	$1.16 - $2.74 $15,394 - $36,362	-13,271 Reduced 17.89%	60,928 $73,000
Q3 2021 Nov 12, 2021	BUY	$2.62 - $5.43 $194,401 - $402,900	74,199 New	74,199 $195,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $10.4M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.